Montreal, Canada

Malika Oubaha

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Malika Oubaha: Innovator in Cellular Senescence Modulation

Introduction

Malika Oubaha is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of cellular senescence, particularly through her innovative research and patent work. Her dedication to advancing scientific knowledge has positioned her as a key figure in her area of expertise.

Latest Patents

Malika Oubaha holds a patent for "Compositions comprising SASP modulators and senescence attenuators and uses thereof for modulating cellular senescence." This patent describes compositions and methods for modulating cellular senescence in cells and inducing the senescence-associated secretory phenotype (SASP). The methods involve modulating the level or activity of IRE1a to control cellular senescence and the induction of the SASP. Additionally, the patent outlines methods for treating and preventing ocular vascular diseases by using biguanide compounds in ophthalmic compositions.

Career Highlights

Malika Oubaha is associated with Rsem, Limited Partnership, where she continues to explore innovative solutions in her field. Her work has garnered attention for its potential applications in treating various diseases related to cellular senescence.

Collaborations

Malika collaborates with notable colleagues, including Przemyslaw Sapieha and Frédérick Antoine Mallette. These partnerships enhance her research and contribute to the advancement of knowledge in cellular senescence.

Conclusion

Malika Oubaha's contributions to the field of cellular senescence modulation are noteworthy. Her innovative patent and collaborative efforts reflect her commitment to advancing scientific research and improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…